MaNaDr is a Singapore-based telehealth platform that connects patients with doctors via a mobile app. The core product is teleconsultation: users open the app, get matched with a doctor from MaNaDr's in-house team or its network of over 700 partner clinics, and conduct a real-time video or text consultation. After the consult, doctors can issue electronic medical certificates and prescriptions, with medications delivered to the user's home. Consultations run roughly US$6–15 per session and are available 24/7. MaNaDr had over 950,000 registered users and more than 1,500 medical professionals on the platform as of mid-2025. Beyond teleconsultation, MaNaDr operates three adjacent businesses: MaNaShop, a B2C e-commerce platform selling OTC medications, supplements, and health products; MaNaPharma, a B2B wholesale distributor of pharmaceuticals and medical devices to clinics; and MaNaCare, a corporate health benefits platform sold to employers on a subscription basis. MaNaDr earns revenue from per-consultation fees, e-commerce product sales, marketplace commissions, B2B pharmaceutical supply, and corporate contracts. The company's growth strategy centers on expanding across Southeast Asia and APAC, building out chronic disease and weight management programs as recurring-revenue use cases, and deepening integrations with insurers and corporate clients.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →